OBIO Orchestra BioMed Holdings, Inc.
$6.12▲ +5.34%
Healthcare
Other
After hours
$6.11▼ -0.16%
Sep 11, 7:30 PM ET
Volume 464.4K
Avg Volume (10D) 323.0K
Key Metrics & Fundamentals
Market Cap
$367.84M
P/E Ratio
–
Div Yield
–%
52W Range
2.20 - 6.25
% vs 50 MA
30.62%
% vs 200 MA
35.34%
RSI-14
69.7
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.32
Free Cash Flow
-$19.59M
Gross Rev
$88,000
Gross Profit
$63,000
EBITDA
-$22.63M
COGS
$25,000
Operating Exp
$22.42M
Operating Income
-$22.36M
EBIT
-$22.36M
Pretax Income
-$23.76M
Net Income
-$23.76M
EPS (Diluted)
-0.38
Price & Volume History
Loading chart…
Recent News
Sector Update: Healthcare Stocks Softer Late Afternoon
MT Newswires · Sep 10, 2026 7:49 PM
Orchestra BioMed Shares Rise After BTIG Upgrade
MT Newswires · Sep 10, 2026 7:11 PM
Top Midday Gainers
MT Newswires · Sep 10, 2026 6:00 PM
BTIG Upgrades Orchestra BioMed to Buy From Neutral, Price Target is $10
MT Newswires · Sep 10, 2026 10:59 AM
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 2, 2026 8:05 PM
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Aug 27, 2026 12:30 PM
Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference
GlobeNewswire · Aug 20, 2026 12:30 PM
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates
Zacks · Aug 10, 2026 9:55 PM
Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
GlobeNewswire · Aug 10, 2026 8:12 PM
Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes
GlobeNewswire · Jun 29, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See OBIO's money flow as a full page
Social Sentiment
No Reddit posts found for OBIO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.